
Bilihome
Wearable jaundice therapy for natural newborn care.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
€140k | Seed | ||
Total Funding | 000k |
Related Content
Bilihome.org is a health-tech startup that provides a unique solution for newborns suffering from jaundice. The company operates in the healthcare market, specifically focusing on neonatal care. Their primary product is a wearable device that provides optimal blue light therapy for jaundiced newborns, allowing them to recover in a comfortable environment.
Jaundice is a common condition in newborns, causing a yellowing of the skin and eyes. It affects 60% of all newborns, with 10% requiring therapy to prevent potential neurological damage. Bilihome's wearable device offers a natural, non-invasive solution to this problem, providing the necessary therapy while allowing the baby to remain with their parents.
The company's business model is based on the sale of these wearable devices. By providing a solution that can be used at home, Bilihome is able to cater to a wide range of clients, from hospitals and healthcare providers to individual parents.
Bilihome's innovative approach to neonatal jaundice treatment has been recognized with the Red Dot: Best of the Best award in the Wearable Technology category. This prestigious award is given for groundbreaking design, further highlighting the company's commitment to providing effective, user-friendly solutions.
Keywords: Health-tech, Neonatal Care, Jaundice, Wearable Device, Blue Light Therapy, Home Treatment, Red Dot Award, Innovative Design, Non-Invasive Solution, Healthcare Market.